2025-05-02 09:06:11
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Vivanza Biosciences Ltd Q3FY23 consolidated net profit up at Rs. 45.85 lakhs
Posted On : 2023-01-25 13:51:29( TIMEZONE : IST )
Vivanza Biosciences Ltd has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 5.8707 crores during the period ended December 31, 2022 as compared to Rs. 1.6513 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.4585 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 0.1692 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 1.15 for the period ended December 31, 2022 as compared to Rs. 0.42 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹5.8707 crs | ₹1.6513 crs |  255.52% |
| Net Profit | ₹0.4585 crs | ₹0.1692 crs | 170.98% |
| EPS | ₹1.15 | ₹0.42 | 173.81% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.5.8707 crores during the period ended December 31, 2022 as compared to Rs.1.5422 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.4585 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-0.0476 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.1.15 for the period ended December 31, 2022 as compared to Rs.-0.12 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹5.8707 crs | ₹1.5422 crs | 280.67% |
| Net Profit | ₹0.4585 crs | ₹-0.0476 crs | 1,063.24% |
| EPS | ₹1.15 | ₹-0.12 | 1,058.33% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.9.9197 crores during the 9 Months period ended December 31, 2022 as compared to Rs.5.0890 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.7020 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.5330 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.1.76 for the 9 Months period ended December 31, 2022 as compared to Rs.1.33 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹9.9197 crs | ₹5.0890 crs | 94.92% |
| Net Profit | ₹0.7020 crs | ₹0.5330 crs | 31.71% |
| EPS | ₹1.76 | ₹1.33 | 32.33% |
Shares of Vivanza Biosciences Ltd was last trading in BSE at Rs. 139.95 as compared to the previous close of Rs. 147.30. The total number of shares traded during the day was 482 in over 24 trades.
The stock hit an intraday high of Rs. 148.50 and intraday low of 139.95. The net turnover during the day was Rs. 67927.00.
